Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: Cytogenetic and molecular analysis of 62 cases and correlation with histological findings

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 1, 2008, Pages 177-181

  Frau, Daniela V ^a   Lai, Maria L ^a   Caria, Paola ^a   Dettori, Tinuccia ^a   Coni, Pierpaolo ^a   Faa, Gavino ^a   Morandi, Luca ^b   Tallini, Giovanni ^b   Vanni, Roberta ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN RET; RAS PROTEIN; TRANSCRIPTION FACTOR PAX8;

ADULT; CHROMOSOME DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; MALE; MOLECULAR GENETICS; OVARY FOLLICLE CELL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVIEW; THYROID NODULE; TRISOMY 17;

EID: 38149053654     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0970     Document Type: Article

References (20)

1. De Lellis, Lloyd R, Heitz PU, Eng C 2004 World Health Organization Classification of Tumors: pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press
2. LiVolsi V, Baloch Z 2004 Follicular neoplasms of the thyroid. View, biases and experiences. Adv Anat Pathol 11:279-287
3. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicularcell neoplasia. Nat Rev Cancer 6:292-306
4. Grieco M, Santoro M, Berlingieri MT, Melillo MR, Donghi R, Bongarzone I, Pienotti MA, Della Porta G, Fusco A, Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563
5. Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G 2006 RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 91:2414-2423
6. Kroll TG, Sarraf P, Pecciarini L, Chen C-J, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science [Erratum (2000) 289:1474] 289:1357-1360
7. Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG 2003 Detection of the PAX8-PPARγ fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88:354-357
8. Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M 2006 PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220
9. Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B 2004 Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40:355-364
10. British Thyroid Association, Royal College of Physicians 2007 Guidelines for management of thyroid cancer. In: Perros P, ed. 2nd ed. Report of Thyroid Cancer Guidelines Update Group. London: Royal College of Physicians
11. Dettori T, Frau DV, Lai ML, Mariotti S, Uccheddu A, Daniele GM, Tallini G, Faa G, Vanni R 2003 Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Genes Chromosomes Cancer 38:22-31
12. Petersen BL, Sørensen MC, Pedersen S, Rasmussen M 2004 Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method. Appl Immunohistochem Mol Morphol 12:259-265
13. Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE 2006 Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab 91:3603-3610
14. Hibi Y, Nagaya T, Kambe F, Imai T, Funahashi H, Nakao A, Seo H 2004 Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPARγ fusion mRNA? Endocr J 51:361-366
15. Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M 2005 A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 36:694-697
16. Garcia-Rostan G, Zhao H, Camp RL, Pollan, Herrero A, Pardo J, Wu R, Carcangiu ML, Costa J, Tallini G 2003 ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 21:3226-3235
17. Roque L, Nunes VM, Ribeiro C, Martins C, Soares J 2001 Karyotypic characterization of papillary thyroid carcinomas. Cancer 92:2529-2538
18. Williams ED 2000 Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181-183
19. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA 2006 Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255-1264
20. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol 160:2157-2167